FDA Authorizes Emergency Use of JYNNEOS Vaccine for Monkeypox

The U.S. Food and Drug Administration (FDA) issued an emergency use authorization for the JYNNEOS vaccine to allow healthcare providers to use the vaccine for individuals 18 years and older who are determined to be at high risk for monkeypox infection.

Visit the Centers for Disease Control and Prevention (CDC) for more information, in English and Spanish, on monkeypox.

Read the full announcement from the FDA here.